Dale Schaar, MD, PhD
I have been at the Cancer Institute of New Jersey since 2002 having completed a fellowship Medical Oncology here at the Cancer Institute of New Jersey (CINJ), which was preceded by my residency in Internal Medicine at The University of Maryland.
I am specialized to care for patients with blood cell cancers with a focus on the myeloid disorders including acute leukemia and myelodysplastic syndromes. In addition, I am one of the stem cell transplant physicians here at the Cancer Institute and therefore, am able to provide all levels of treatment that may be required for these disorders. I am able to provide patients with a comprehensive evaluation — and through consultation with the multidisciplinary teams within the Leukemia/Lymphoma/Hematologic Malignancies and Stem Cell Transplantation Programs, I help educate patients on their treatment options so that they can make an informed decision.
I have a research interest in the molecular basis of acute myelogenous leukemia (AML) and am currently exploring novel genes for their use as biomarkers and potential treatment targets to improve the care of patients with these blood cell cancers. And by having the resources available that can only be found at a National Cancer Institute-designated Comprehensive Cancer Center, our team is able to translate these research findings and directly apply them to patient therapies.
I am the author or co-author of more than 20 publications and serve as the principal or co-investigator on several ongoing clinical trials for patients with blood cell cancers here at CINJ.
Hematologic malignancies, bone marrow transplants, leukemia
Dale Schaar, MD, PhD practices at:
- Main Office
- RWJUH 5 North SDCU
- CINJ- East Tower